Ironwood Pharmaceuticals, Inc. - Class A (IRWD) earnings
IRWD earnings moved a median of +0.11% by the close. Quarterly and annual IRWD reports and results, each read against the price at its own news timestamp. Back to the IRWD overview →
29 measured IRWD earnings events.
Where these IRWD earnings landedvs 28 measured IRWD earnings reactions
| Middle 50% of IRWD earnings reactions | -2.83% to +3.01% |
|---|---|
| Median reaction (to close) | +0.11% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 IRWD earnings events with a measured close landed between -2.83% and +3.01%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q IRONWOOD PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -2.31% | +0.00% | |
| Ironwood Pharmaceuticals Raises 2026 Full-Year Financial Guidance Building on Strong Second Quarter Results | Press release | +4.33% | +2.40% | |
| Ironwood Pharmaceuticals to Host Second Quarter 2026 Investor Update Call | Press release | -0.25% | +7.63% | |
| Form 10-Q IRONWOOD PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.94% | |
| Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance | Press release | -0.37% | -10.90% | |
| Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call | Press release | +0.12% | +7.25% | |
| Form 10-K IRONWOOD PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -3.10% | -3.66% | |
| Form 10-Q IRONWOOD PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +7.33% | +3.69% | |
| Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance | Press release | +7.33% | +3.69% | |
| Form 10-Q IRONWOOD PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +2.61% | — | |
| Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance | Press release | +5.98% | -4.35% | |
| Form 10-Q IRONWOOD PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.91% | -8.01% | |
| Ironwood Pharmaceuticals Reports First Quarter 2025 Results | Press release | -5.34% | -15.80% | |
| Form 10-K IRONWOOD PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -1.46% | +7.30% | |
| Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing | Press release | -0.35% | -2.08% | |
| Form NT 10-K IRONWOOD PHARMACEUTICALS For: Dec 31 | SEC filing · Form NT | -1.35% | +0.68% | |
| Form 10-Q IRONWOOD PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +1.48% | +5.08% | |
| Ironwood Pharmaceuticals Reports Third Quarter 2024 Results | Press release | +10.75% | +8.88% | |
| Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call | Press release | -0.63% | -1.00% | |
| Form 10-Q IRONWOOD PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +5.08% | +2.66% | |
| Ironwood Pharmaceuticals Reports Second Quarter 2024 Results | Press release | -4.08% | -32.50% | |
| Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call | Press release | +2.17% | +2.03% | |
| Form 10-Q IRONWOOD PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -1.10% | +2.79% | |
| Ironwood Pharmaceuticals Reports First Quarter 2024 Results | Press release | +4.34% | -0.88% | |
| Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call | Press release | -0.31% | -3.34% | |
| Form 10-K IRONWOOD PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -0.47% | -2.60% | |
| Form 10-Q IRONWOOD PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -0.41% | +0.72% | |
| Ironwood Pharmaceuticals Reports Third Quarter 2023 Results | Press release | -1.90% | +0.21% | |
| Ironwood Pharmaceuticals to Host Third Quarter 2023 Investor Update Call | Press release | -1.44% | -2.66% |
Keep exploring
More IRWD: analyst actions → · SEC filings → · IRWD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| REGENERX BIOPHARMS INC (RGRX) | 343 | 0.00% | 36% |
| Allena Pharmaceuticals, Inc. (ALNA) | 342 | 0.00% | 41% |
| Brookdale Senior Living Inc. (BKD) | 341 | +0.36% | 62% |
| Vaxart, Inc. (VXRT) | 341 | -0.81% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.